Wesco Insider Activity: 125,001 SARs Exercised and Shares Sold by CEO
Rhea-AI Filing Summary
John Engel, Chairman, President & CEO of Wesco International Inc. (WCC), reported multiple transactions on 08/26/2025 and 08/27/2025. He exercised 125,001 stock appreciation rights with a conversion/exercise price of $62.80, resulting in 125,001 shares issued. On the same dates he sold a total of 125,001 shares in multiple transactions at weighted average prices ranging from $224.30 to $227.62, with reported weighted prices of $225.01, $225.74, $226.88 and $227.47 for specific sale groups. Following these transactions his beneficial ownership is reported as 475,971.1888 shares.
Positive
- Exercise of SARs: 125,001 Stock Appreciation Rights were exercised at a $62.80 exercise price, resulting in issuance of 125,001 shares.
- Timely disclosure: Transactions were reported on a Form 4 with explanatory footnotes and an attorney-in-fact signature.
Negative
- Large insider sales: 125,001 shares were sold in multiple transactions at weighted prices ranging up to $227.62, reducing beneficial ownership.
- Potential dilution: The SAR exercise resulted in new shares issued (125,001) which may increase outstanding share count (documented issuance).
Insights
TL;DR: Insider exercised SARs and immediately sold an equal number of shares, leaving reported beneficial ownership at 475,971.1888 shares.
The Form 4 shows an exercise of 125,001 stock appreciation rights at a $62.80 exercise price, producing 125,001 common shares. Subsequent sales on 08/26-08/27/2025 disposed of 125,001 shares across several transactions at weighted average prices within the $224.30–$227.62 ranges, with reported weighted averages for blocks at about $225–$227. The net effect is a reduction from 600,972.1888 shares pre-sales to 475,971.1888 shares post-sales. These are routine insider liquidity actions following SAR vesting and are informational for share supply and insider behavior.
TL;DR: The filing documents standard executive exercises and market sales tied to vested SARs; no governance irregularities disclosed.
The record indicates vested Stock Appreciation Rights became exercisable in installments and 125,001 were exercised on 08/26/2025. The concurrent sales of an equal number of shares were disclosed with weighted average sale prices across multiple execution ranges. The Form 4 is properly signed by an attorney-in-fact and contains explanations for price ranges. There is no information in this filing indicating policy deviations, related-party issues, or unusual delays in disclosure.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,501 | $225.01 | $2.36M |
| Sale | Common Stock | 17,875 | $225.74 | $4.04M |
| Sale | Common Stock | 16,240 | $226.88 | $3.68M |
| Sale | Common Stock | 6,435 | $227.47 | $1.46M |
| Exercise | Stock Appreciation Rights | 125,001 | $0.00 | -- |
| Exercise | Common Stock | 125,001 | $62.80 | $7.85M |
| Disposition | Common Stock | 34,660 | $226.49 | $7.85M |
| Tax Withholding | Common Stock | 39,290 | $226.49 | $8.90M |
Footnotes (1)
- Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $224.30 to $225.29. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided. Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $225.30 to $226.27. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided. Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $226.32 to $227.31. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided. Represents weighted average sale price. These shares were sold in multiple transactions at prices ranging from $227.32 to $227.62. Upon request by the SEC, the Issuer or a stockholder of the Issuer, complete information regarding the number of shares sold at each price within the range will be provided. The Stock Appreciation Rights became exercisable in three (3) equal, annual installments beginning on the first anniversary of the February 13, 2018 grant date.